Gender‐and sex‐specific differences in medicine were long‐time disregarded. Despite
numerous indications of gender‐and sex‐specific influences on the treatment of …

The effect of sex on systemic therapy for psoriasis has not been well studied. The aim of this
study was to analyse a large multicentre Spanish cohort of 2,881 patients with psoriasis …

Biologics are important treatment options for psoriasis; however, direct comparison of their
efficacy, safety, and drug survival is insufficient in clinical practice. This retrospective single …

Persistence is an important component of therapeutic success, which depends on a variety
of factors. Persistence measured under optimal conditions during clinical trials does not …

Background Data for the effect of metabolic syndrome (MetS) on the efficacy and safety of
biologic agents for psoriasis treatment are limited. Objective To evaluate long-term …

Abstract Background: The Swiss psoriasis registry SDNTT (Swiss Dermatology Network for
Targeted Therapies) records the long-term safety and effectiveness of systemic treatment …

Purpose Multiple biological therapies have been developed for the treatment of
inflammatory diseases, including moderate to severe plaque psoriasis. Choosing the …

Lebrikizumab improved itch and reduced the extent of itch interference on sleep in patients
with moderate-to-seve Page 1 270 Research Letters British Association of Dermatologists …

Abstract Background/Objective: The purpose of our study was to provide evidence on the
treatment choices, reasons, and results of switching between biologic agents in treating …

Introduction Patients with moderate-to-severe plaque psoriasis who experience poor clinical
outcomes, including patients with obesity or prior treatment, need improved treatment …